Immunotech Biopharm Ltd (6978.HK)
Develops T cell cancer treatments tested in Chinese patients.
0.37+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-90.7%
The outlook
Immunotech Biopharm is trading near its 52-week low at 0.37, well below both its 50- and 200-day moving averages. Analyst coverage appears sparse. The overall sentiment is bearish, reflecting a stock deep in its recent trading range with minimal upward positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$228.5M
52-wk high
5.83
52-wk low
0.33
50-day avg
0.61
200-day avg
2.21
Trailing P/E
—